Search

Search Constraints

You searched for: Author/Creator Berenato, Rosa

Search Results

1. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer. Issue 2 (November 2015)

2. Baseline neutrophilia, derived neutrophil‐to‐lymphocyte ratio (dNLR), platelet‐to‐lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel. Issue 10 (19th April 2018)

3. Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients. (January 2017)

4. Early onset metastatic colorectal cancer in patients receiving panitumumab‐based upfront strategy: Overall and sex‐specific outcomes in the Valentino trial. Issue 10 (23rd June 2022)

5. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. Issue 1 (December 2016)

6. Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer. Issue 4 (July 2016)

7. Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. (5th July 2016)

8. Location of Primary Tumor and Benefit From Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild‐Type Metastatic Colorectal Cancer. (5th July 2016)

9. Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study. (25th January 2022)

10. Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope. (7th October 2015)